MD and CEO Pankaj Jashwant Shah resigns from Aspira Pathlab
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 3.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Pankaj Jashwant Shah has resigned as Managing Director and CEO of Aspira Pathlab and Diagnostics effective August 3, 2026, citing personal reasons. The exit is immediate. The board has been informed and no replacement has been named yet.
Sudden exit at the top. Watch for stock reaction and announcement of a new MD and CEO, which could shape future direction.